ZA969320B - Treatment of traumatic brain injury - Google Patents

Treatment of traumatic brain injury

Info

Publication number
ZA969320B
ZA969320B ZA969320A ZA969320A ZA969320B ZA 969320 B ZA969320 B ZA 969320B ZA 969320 A ZA969320 A ZA 969320A ZA 969320 A ZA969320 A ZA 969320A ZA 969320 B ZA969320 B ZA 969320B
Authority
ZA
South Africa
Prior art keywords
treatment
brain injury
traumatic brain
traumatic
injury
Prior art date
Application number
ZA969320A
Other languages
English (en)
Inventor
Brian R Pike
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA969320B publication Critical patent/ZA969320B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA969320A 1995-11-06 1996-11-06 Treatment of traumatic brain injury ZA969320B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06

Publications (1)

Publication Number Publication Date
ZA969320B true ZA969320B (en) 1997-05-30

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969320A ZA969320B (en) 1995-11-06 1996-11-06 Treatment of traumatic brain injury

Country Status (18)

Country Link
EP (1) EP0866706A1 (cs)
JP (1) JPH11514654A (cs)
KR (1) KR19990067353A (cs)
AU (1) AU706594B2 (cs)
BG (1) BG63150B1 (cs)
BR (1) BR9611396A (cs)
CA (1) CA2234824A1 (cs)
CZ (1) CZ287441B6 (cs)
EA (1) EA000531B1 (cs)
HU (1) HUP9901051A2 (cs)
IS (1) IS4726A (cs)
NO (1) NO982036L (cs)
NZ (1) NZ321546A (cs)
PL (1) PL326490A1 (cs)
SK (1) SK58198A3 (cs)
TR (1) TR199800801T2 (cs)
WO (1) WO1997017074A1 (cs)
ZA (1) ZA969320B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
RU2266737C1 (ru) * 2004-04-12 2005-12-27 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Россиской Академии Наук Препарат для лечения геморрагического инсульта и способ лечения геморрагического инсульта
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
EP0866706A1 (en) 1998-09-30
NZ321546A (en) 2000-12-22
SK58198A3 (en) 1998-10-07
TR199800801T2 (xx) 1998-08-21
AU706594B2 (en) 1999-06-17
CZ287441B6 (en) 2000-11-15
AU7490096A (en) 1997-05-29
NO982036L (no) 1998-06-25
EA000531B1 (ru) 1999-10-28
BR9611396A (pt) 1999-07-13
MX9803432A (es) 1998-09-30
KR19990067353A (ko) 1999-08-16
WO1997017074A1 (en) 1997-05-15
CA2234824A1 (en) 1997-05-15
BG102480A (en) 1999-01-29
IS4726A (is) 1998-04-27
HUP9901051A2 (hu) 2000-03-28
JPH11514654A (ja) 1999-12-14
EA199800434A1 (ru) 1998-10-29
NO982036D0 (no) 1998-05-05
CZ138998A3 (cs) 1998-10-14
BG63150B1 (bg) 2001-05-31
PL326490A1 (en) 1998-09-28

Similar Documents

Publication Publication Date Title
AU1436595A (en) Method of treatment of traumatic brain injury
GB9401520D0 (en) Treatment of poultry
IL119747A0 (en) Treatment of vegetables
ZA969520B (en) Use of epinastine for the treatment of pain
ZA96740B (en) Skin treatment composition
EP0795035A4 (en) SKIN TREATMENT
ZA969320B (en) Treatment of traumatic brain injury
GB9222260D0 (en) Skin treatment
GB2303303B (en) Medical treatment
IL131347A0 (en) Treatment of skin disorders
GB9518887D0 (en) Treatment of muscular disorders
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP0828507A4 (en) METHOD FOR TREATING PAIN
GB9507825D0 (en) Method of treatment
GB9216360D0 (en) Treatment of blood
IL119282A0 (en) Treatment of fowl
GB9415902D0 (en) Method of treatment
AU4128896A (en) Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
ZA936136B (en) Treatment of skin diseases
GB9407335D0 (en) Method of treatment
GB9218773D0 (en) Skin treatment
AU3805497A (en) Calpain inhibitors for the treatment of traumatic brain injury
GB9520494D0 (en) Treatment of medical conditions
GB9520496D0 (en) Treatment of medical conditions
GB9520495D0 (en) Treatment of medical conditions